The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor

Clinical trial NCT01018485 · COMPLETED

Trial details

NCT number: NCT01018485
Sponsor: Melbourne Health
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis Tremor

Start date: 2008-10-01
Primary completion: 2010-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.